Skip to main content
Premium Trial:

Request an Annual Quote

S2 Genomics, Riken Partner on Single-Cell Genomics Applications

NEW YORK – S2 Genomics said on Tuesday that Japan's RIKEN Center for Integrated Medical Sciences will evaluate and further develop single-cell sequencing applications on the S2 Genomics' Singulator tissue prep system under and early-access program.  

According to Livermore, California-based S2 Genomics, the Singulator platform combines enzymatic and mechanical disruption to produce suspensions of cells or nuclei for downstream single-cell applications.

S2 Genomics plans to commercially launch the platform later this year as a research-use-only instrument.

"The Singulator automates and standardizes the dissociation of solid tissues and can improve the quality of single-cell and single-nuclei data from a variety of solid tissue types," S2 Genomics CEO and President Stevan Jovanovich said in a statement. "We are excited to work with the RIKEN IMS to evaluate the performance of the system and to develop new applications for the Singulator platform."

The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.